Clinical Trial Update: A Study of HRS-5632 in Adult Participants With Elevated Lipoprotein(a) at High Risk for Cardiovascular Events [Phase 2]

View source ↗

Summary

Phase 2 study evaluating HRS-5632 in adults with elevated lipoprotein(a) at high risk for cardiovascular events; the trial is currently active but not recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Hyperlipoproteinemia

Drugs mentioned

• HRS-5632

Snippet

Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd. | Conditions: Lipoprotein Disorder | Phase 2 | Status: ACTIVE_NOT_RECRUITING